FII Holdings

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE1256.356.05 (+0.48 %)
PREV CLOSE ( ) 1250.30
OPEN PRICE ( ) 1279.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 48295
TODAY'S LOW / HIGH ( )1239.60 1309.00
52 WK LOW / HIGH ( )392.6 1297.75
NSE1254.558.2 (+0.66 %)
PREV CLOSE( ) 1246.35
OPEN PRICE ( ) 1264.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 734660
TODAY'S LOW / HIGH( ) 1242.30 1309.90
52 WK LOW / HIGH ( )393 1296.65
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202409 % of Share Quarter Ended 202406 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.